12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • NeuroOne Medical Tech NMTC shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5 million. The company's, Q1 earnings came out 3 days ago.
  • Biofrontera BFRA stock rose 11.85% to $3.49. The market value of their outstanding shares is at $98.9 million.
  • Paratek Pharmaceuticals PRTK stock rose 9.76% to $4.27. The company's market cap stands at $214.3 million.
  • Revelation Biosciences REVB stock rose 9.41% to $2.44. The market value of their outstanding shares is at $34.7 million.
  • INmune Bio INMB stock rose 9.38% to $12.0. The market value of their outstanding shares is at $214.1 million.
  • Rhythm Pharmaceuticals RYTM stock moved upwards by 7.08% to $7.1. The market value of their outstanding shares is at $356.9 million.

Losers

  • 10x Genomics TXG stock decreased by 23.7% to $72.5 during Thursday's pre-market session. The market value of their outstanding shares is at $8.0 billion. As per the news, the Q4 earnings report came out yesterday.
  • Marker Therapeutics MRKR shares fell 19.03% to $0.5. The company's market cap stands at $41.5 million. The company's, Q4 earnings came out yesterday.
  • Larimar Therapeutics LRMR stock fell 7.11% to $3.66. The market value of their outstanding shares is at $64.8 million.
  • Dermata Therapeutics DRMA stock fell 6.35% to $1.18. The market value of their outstanding shares is at $9.8 million.
  • Orphazyme ORPH stock fell 5.01% to $2.09. The market value of their outstanding shares is at $73.0 million.
  • Biolase BIOL stock fell 4.45% to $0.39. The market value of their outstanding shares is at $60.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...